SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Investor Presentation

1 Oct 2025 13:22

RNS Number : 6691B
Ebiquity PLC
01 October 2025
 

Ebiquity plc

1 October 2025

 

Investor Presentation

Ebiquity plc ("Ebiquity" or the "Group"), a world leader in media investment analysis, reminds investors and potential investors that the leadership team will provide a live presentation relating to its interim results for the six months ended 30 June 2025 via the Investor Meet Company platform on Thursday 2 October 2025 at 13:00 BST.

 

The presentation is open to all existing and potential shareholders. Questions can be submitted in advance via your Investor Meet Company dashboard up until Wednesday 1 October 2025 at 09.00 BST, or at any time during the live presentation.

 

Investors can sign up to Investor Meet Company for free and register to attend the presentation via:

https://www.investormeetcompany.com/ebiquity-plc/register-investor

 

Investors who already follow Ebiquity on the Investor Meet Company platform will automatically be invited. 

 

Enquiries: 

 

Ebiquity plc

+44 (0) 20 7650 9600

Dorcas Murray, Company Secretary

Camarco

Phoebe Pugh

+44 (0) 7586 714 048

Alex Campbell

+44 (0) 7710 230545

Cavendish Capital Markets

Nominated Advisor and Sole Broker

+44 (0) 20 7220 0500

Ben Jeynes/ George Lawson - Corporate Finance

Julian Morse/ Louise Talbot/ Sunila de Silva - Sales/ ECM

 

About Ebiquity plc

 

Ebiquity is a world leader in media investment analysis. Trusted by more than 75 of the top 100 global advertisers - and 500 more worldwide - we analyse over $100 billion in media spend each year. This unmatched scale gives us the deepest data and the sharpest insights in the industry, powering the impartial advice our clients act on to make the right decisions that deliver Effective and Responsible Advertising.

 

Our work is driven by 650 media experts on the ground in 19 countries. Covering more than 80% of the world's media market, we are the most local and the most global, ensuring local relevance with global consistency.

 

With our evidence-based consultancy, clients transform their media operations, strengthen governance of their investments, and unlock significant incremental business growth.

 

On average, our clients achieve a 15% improvement in ROI and collectively generate over $1 billion in value annually through our digital governance programmes.

 

For further information, please visit: www.ebiquity.com

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFSSFEFEISEES
Date   Source Headline
25th Jun 20187:15 amRNSStatement re CMA Phase 2 referral
15th Jun 20187:00 amRNSPartnership with Snapchat to enhance measurement
13th Jun 20187:05 amRNSStatement re CMA review of disposal
1st Jun 20189:15 amRNSTotal Voting Rights
18th May 201812:20 pmRNSHolding(s) in Company
9th May 201812:11 pmRNSAGM Resolutions Passed
9th May 20187:00 amRNSIssue of Shares
1st May 20181:10 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSDirector/PDMR Shareholding
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:05 pmRNSHolding(s) in Company
21st Mar 20183:00 pmRNSDividend Declaration
21st Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSTotal Voting Rights
27th Feb 20187:00 amRNSDirectorate Change
19th Feb 20187:00 amRNSIssue of Shares
13th Feb 20182:00 pmRNSDirector/PDMR dealing and grant of options
13th Feb 20187:00 amRNS£26m disposal and pre-close trading statement
2nd Jan 20184:45 pmRNSTotal Voting Rights
19th Dec 20177:00 amRNSDirectorate Change
28th Nov 201710:15 amRNSHolding(s) in Company
17th Nov 201712:01 pmRNSIssue of Shares
8th Nov 20173:00 pmRNSIssue of Shares
26th Sep 20177:00 amRNSInterim Results
19th Sep 20175:50 pmRNSHolding(s) in Company
31st Aug 20172:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNSIssue of Shares
21st Aug 20177:00 amRNSIssue of Shares
17th Aug 20178:52 amRNSIssue of Shares
8th Aug 20177:00 amRNSExercise of Share Options and dealing by PDMR
3rd Aug 20177:00 amRNSInterim trading statement
11th Jul 20177:00 amRNSEbiquity Launches Total View Attribution service
4th Jul 20177:00 amRNSEbiquity Launches Media Transparency Score tool
31st May 20171:00 pmRNSTotal Voting Rights
11th May 20175:05 pmRNSExercise of Share Options
10th May 201711:16 amRNSResult of AGM
2nd May 201711:05 amRNSDirector/PDMR Shareholding
21st Apr 20173:00 pmRNSAwards extension
20th Apr 20177:00 amRNSEbiquity launches 'Portfolio Digital' in the UK
18th Apr 201710:05 amRNSAnnual Report
29th Mar 201711:02 amRNSDividend Declaration
28th Mar 20177:00 amRNSFinal Results
10th Mar 20173:30 pmRNSHolding(s) in Company
26th Jan 20177:00 amRNSPre-close trading statement
2nd Dec 201612:15 pmRNSDeferred Consideration/Issue of Ordinary Shares
11th Nov 20162:48 pmRNSHolding(s) in Company
14th Oct 201612:30 pmRNSRe Directorate
6th Oct 20167:00 amRNSLaunch of Strategic Media Consultancy service
28th Sep 20167:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.